Posted on 5/8/18
Epizyme Reports First Quarter 2018 Financial Results and Provides Business Updates
CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage company developing novel epigenetic therapies, today reported financial results for the first quarter . . .
Posted on 5/8/18
Momenta Pharmaceuticals Provides Corporate Update
CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the first quarter ended March 31, 2018 and . . .
Posted on 5/8/18
Elliott Management To Athenahealth: The Stock Price Tells The Story
On May 7, 2018, Elliott Management Corp. issued a press release containing a letter that was delivered to athenhealth (ATHN), which includes, among other things, a . . .
Posted on 5/7/18
Loxo Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
STAMFORD, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically . . .
Posted on 5/7/18
Karyopharm Therapeutics Closes Public Offering of Common Stock
NEWTON, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the closing of its previously announced registered underwritten . . .
Posted on 5/7/18
Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer
CAMBRIDGE, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined . . .
Posted on 5/7/18
Athenahealth Up 21% Premarket On Elliot Bid Of $155 - 160
Athenahealth (NASDAQ:ATHN) is up 21% premarket on the news that Paul Singer's Elliot Management has made a $155 - 160 bid for the company.Friday's close was . . .
Posted on 5/6/18
AAPA's Center for Healthcare Leadership and Management Partners with Northeastern University
American Academy of PAs' (AAPA) Center for Healthcare Leadership and Management (CHLM) announced a partnership with Northeastern University in Boston to offer a graduate certificate in . . .
Posted on 5/6/18
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq: VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced the grant . . .
Posted on 5/6/18
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., May 04, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of . . .
Posted on 5/4/18
KaryoPharma Therapeutics: A Strong Horse In A Weak Market
"The most critical time in any battle is not when I'm fatigued, it's when I no longer care." - Craig D. LounsbroughToday, we take a look . . .
Posted on 5/4/18
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
NEWTON, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the pricing of its previously announced registered underwritten . . .
Posted on 5/4/18
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for . . .
Posted on 5/4/18
uniQure Announces Pricing of its Public Offering
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, May 02, 2018 (GLOBE NEWSWIRE) -- uniQure N.V.(Nasdaq:QURE), a leading gene therapy company advancing transformative therapies for patients with severe . . .
Posted on 5/4/18
Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
CAMBRIDGE, Mass. & KENILWORTH N.J.--(BUSINESS WIRE)--Moderna Therapeutics and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced an expansion of their 2016 . . .
Posted on 5/4/18
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on May . . .
Posted on 5/4/18
Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics
CAMBRIDGE, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine . . .
Posted on 5/4/18
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BURLINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to seven new employees for an . . .
Posted on 5/3/18
Minerva Neurosciences Reports First Quarter 2018 Financial Results and Business Updates
WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous . . .
Posted on 5/2/18
Achillion Reports First Quarter 2018 Financial Results and Management Transition
NEW HAVEN, Conn., May 02, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a biopharmaceutical company focused on advancing oral small-molecule factor D inhibitors to modulate . . .
Posted on 5/2/18
ProMIS Neurosciences Closes $7.2 Million Private Placement
ProMIS Neurosciences Inc. (TSX:PMN; OTCQB:ARFXF) is pleased to announce that it closed yesterday a private placement of 19,306,668 Units at the price of CDN$0.375 per Unit . . .
Posted on 5/2/18
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
NEWTON, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the commencement of a registered underwritten public offering . . .
Posted on 5/2/18
uniQure Announces Proposed Public Offering
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 01, 2018 (GLOBE NEWSWIRE) -- uniQure N.V.(Nasdaq:QURE), a leading gene therapy company advancing transformative therapies for patients with severe . . .
Posted on 5/2/18
Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline . . .
Posted on 5/1/18
Loxo Oncology to Announce First Quarter 2018 Financial Results
STAMFORD, Conn., May 01, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically . . .

